In accordance with Article 61 of Federal Law On the Circulation of Pharmaceuticals, the marginal prices established by manufacturers of medicines listed as vitally important and highly important pharmaceuticals are subject to government registration in accordance with the procedure established by the Government of the Russian Federation.
Events
Law on state regulation of pharmaceutical prices
Vladimir Putin signed Federal Law On Amending Article 61 of Federal Law On the Circulation of Pharmaceuticals.